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Type 1 diabetes mellitus (T1DM) is a chronic immune-mediated disease. 
Diabetic peripheral neuropathy (DPN) is an important microvascular 
complication of T1DM. One of the most important risk factors for the 
development of DPN is poor glycemic control. We evaluated the prevalence 
of DPN among T1DM patients and determined the association between 
DPN and glycated hemoglobin (HbA1c) level. 
Materials & Methods 
The subjects were recruited prospectively upon initial evaluation at 
Imam Reza Hospital, Mashhad, Iran from Jan 2013 to Jan 2015. Patients 
with T1DM were selected based on the inclusion criteria (i.e., age of 
6≤yr and absence of other co-morbidities). DPN was assessed through 
electrodiagnostic studies and neurological examinations, while diabetes 
control was evaluated by measuring the HbA1c level. 
Results 
Fifty patients with T1DM were enrolled in this study. The mean diabetes 
duration of patients was 8.38±3.79 yr (mean age16.68±6.68 yr). The mean 
HbA1c level was 8.6±2.1% in patients without DPN and 10.5±3 in those 
with DPN (P=0.016). Overall, 24% of the subjects were presented with 
DPN according to nerve conduction velocity study (NCV) findings. A 
positive correlation was found between NCV and clinical symptoms with 
signs (P<0.001, r=0.45 and P<0.001, r=0.644, respectively). Sensitivity 
and specificity of neurological examination for DPN diagnosis were 91.7% 
and 63.2%, respectively. Poor diabetes control is associated with DPN. 
Moreover, HbA1c level was used as an index for glycemic control over the 
past 3 months.
Conclusion
Rigid blood glucose control and periodic neurological examinations were 
the best strategies to prevent DPN. 
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Introduction 
Type 1 diabetes mellitus (T1DM) is a chronic 
immune-mediated disease, in which the pancreas 
ceases to produce enough insulin (1). The overall 
increase in the incidence of T1DM was estimated 
at nearly 3%, and the annual incidence of this 
condition varied from 0.61 cases per 100000 
populations in China to 57.6 cases per 100000 in 
Finland (2, 3). Middle East region, Saudi Arabia 
and Kuwait have the highest incidence rate at 31.4 
and 22.3/100000 per year (4).
Annually, 1 to 35 new cases of T1DM (younger 
than 14 yr) per 100000 populations are diagnosed 
per year. In various countries, the incidence rate of 
T1DM has at least doubled over the past two decades. 
The incidence of this condition seems to raise as the 
distance from the equator increases (5, 6). 
Peripheral nervous system involvement is a 
common complication of T1DM, and unlike 
adults, patient’s polyneuropathy has no clinical 
manifestations in diabetic children (7). The 
prevalence of neuropathy varies depending on the 
severity and duration of hyperglycemia (1). The 
prevalence of peripheral neuropathy in both adults 
and children ranges between 7% and 57% (8).
Nerve conduction velocity (NCV) test is the 
method of choice for the diagnosis of neuropathy. 
The incidence of neuropathy in different studies 
ranges from 10% to 68% among diabetic patients 
(9, 10). 
In this study, we evaluated the sign and symptoms 
of peripheral polyneuropathy and its correlation 
with glycated hemoglobin (HbA1c) level as an 
indicator of metabolic control in diabetic patients 
in Mashhad City, Eastern Iran.
Materials & Methods
 The subjects were recruited prospectively upon initial 
evaluation at Imam Reza Hospital, Mashhad, Iran 
from Jan 2013 to Jan 2015. Patients with T1DM were 
selected based on the inclusion criteria, i.e., age of six 
years or older, and absence of other comorbidities. On 
the other hand, patients with neurological disorders, 
such as mental retardation, secondary diabetes, 
systemic diseases, or maturity-onset diabetes of the 
young were excluded from the study.
Ethics Committee of Mashhad University of 
Medical Sciences approved this study. Written 
consent forms were obtained from all study 
subjects. 
Anthropometric data including body mass index 
(BMI), weight, and height were measured while 
recruiting the participants. HbA1c level and lipid 
profile were analyzed by applying the immune 
turbid metric method (BT3000 analyzer, Italy). 
An expert neurologist and endocrinologist 
to determine DPN was carried out a detailed 
neurological examination. Vibration perception, 
temperature sensation, pinprick sensation, MMT 
and ankle reflex were also examined in the 
participants. A tuning fork (128 Hz), Semmes-
Weinstein monofilament test, cold and warm 
water test, and a reflex hammer were used for 
the evaluations. Neuropathy was evaluated 
through electrodiagnostic studies. The reference 
for evaluation and comparison of the electro-
diagnostic parameters of sensorimotor responses 
were based on the tables from the “Electrodiagnosis 
in diseases of the nerve and muscle” and “electro-
diagnostic medicine”. The evaluation was done in 
a calm room with optimal lighting and temperature 
was at 24-degree Celsius. Patients’ skin surface 
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temperature was approximately 34 degrees Celsius, 
at the time of evaluation.
The sensory nerves evaluated were the median 
and ulnar nerves in the upper limbs, Sural and 
superficial peroneal nerves in the lower limbs, 
and sural as well as superficial peroneal nerves in 
lower limbs. The methods used for the stimulation, 
recording, and analysis of the data were based on 
the standards of the books aforementioned.
NCV and distal latency tests were performed in 
the following nerves: Common peroneal nerve, 
tibial nerve, superficial peroneal nerve, and sural 
(sensory) nerve in the lower extremities, as well 
as median (motor and sensory) nerves in the 
upper extremities, were observed in the tests. 
Electrodiagnostic studies were conducted by 
one single operator and device (Myto, Italy). We 
evaluated 50 diabetic patients, divided into two 
groups: group A with abnormal NCV, and group B 
with normal NCV.
Normality of variables was tested by Kolmogorov–
Smirnov test. Then, parametric or non–parametric 
tests were performed to determine the difference 
and relationship between variables. For data 
analysis, SPSS Ver. 16 (Chicago, IL, USA) was 
applied, and the collected data with referral codes 
were imported into the software. P-value less than 
0.05 were considered statistically significant. 
Results
FiftyT1DM patients with the mean age of 
16.68±6.98 yr and disease duration of 8.36±3.79 
yr were enrolled (Table 1). Overall, 54% (n=27) 
of the participants were female. Twenty one (42%) 
patients were clinically asymptomatic, while 
29 (58%) cases had at least one of the signs or 
symptoms of peripheral neuropathy. Abnormal 
pain sensation was detected in 9 (18%) patients, 
and the frequency of paresthesia, numbness, 
and burning sensation was 6%, 28%, and 8%, 
respectively; in total, and 30 (60%) patients had 
one abnormal symptom. Neurological examination 
was suggestive of impaired temperature sensation 
in 6 (12%) cases. Reduced vibration perception, 
abnormal Achilles reflex, and impaired touch 
perception were reported in 5 (10%), 15 (30%), 
and 3 (6%) cases, respectively; overall, 29 (58%) 
patients had one abnormal sign. Abnormal Achilles 
reflex and numbness were the most common 
findings in our study population (Table 2).





Sex (male/female) 3/9   20/18 0.094
Age (yr) 19.7±10.1    15.7±5.4 0.20
Diabetes duration (years) 11.3±9.4     7.4±3.7 0.18
BMI (kg/m2) 21.1±2.6     19.7±3.3 0.16
Triglyceride (mg/dl) 105.6±66.5   83.7±44.7 0.35
Cholesterol (mg/dl) 158.33±34.8  188.7±64.4 0.28
HbA1c 10.58±3.05    8.63±2.1 0.016
Data are presented as Mean±SD
BMI: Body mass index; TG: Triglyceride; TC: Total cholesterol, HbA1c: Glycated hemoglobin
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Based on the comparison between the two groups 
by Kappa coefficients, clinical signs were not 
significantly associated with peripheral neuropathy, 
while a significant correlation was found between 
peripheral neuropathy and clinical symptoms 
(Table 3). NCV was normal in 38 (76%) patients 
and abnormal in 12(24%) cases. The mean HbA1c 
level was 8.6±2.1 (mmol/ml) in patients without 
peripheral neuropathy, and 10.5±3 in those with 
peripheral neuropathy (P=0.016) (Table 1).
Discussion 
Diabetic neuropathy is a major complication of 
T1DM. This term usually refers to polyneuropathy 
and can be classified into two broad subclinical 
and clinical stages. The prevalence of diabetic 
neuropathy in developing countries ranges between 
10% and 68% (9,11). In Western countries, up to 
60% of all patients with diabetes are affected by 
diabetic neuropathy (10). However, the estimated 
rates of children are inaccurate, considering the 
prevalence of subclinical diabetic neuropathy 
observation in this age group.
In the present study, DPN was reported in 24% 
of the patients, according to the electrodiagnostic 
studies, while 25% of these cases were clinically 
asymptomatic. Nearly one-fourth of young 
patients who recently diagnosed with diabetes 









Burning sensation 3 (25) 1(2.6) 4 (8)
Pain sensation 3 (25) 6(15.8) 9 (18)
Paresthesia 2 (16) 1(2.6) 3 (6)




6 (50) 0 (0) 6 (12)
Reduced pain sensa-
tion
0 (0) 0 (0) 0 (0)
Reduced vibration 
perception
5 (41.7) 0 (0) 5(10)
Impaired touch per-
ception
3(25) 0 (0) 3(6)
Abnormal Achilles 
reflex
9 (75) 6 (15.8) 15 (30)
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had pathological findings in the distal nerves (9). 
Moreover, subclinical DPN was reported in up to 
60% of patients in Isfahan, Iran (12). Various studies 
have introduced diabetes duration as a major factor 
in DPN development (11, 13-16), although this 
finding has not been confirmed in other studies 
(17, 18), similar to the present research. On the 
other hand, diabetic neuropathy and abnormal NCV 
findings have been reported in patients with recently 
diagnosed diabetes by some researchers (14, 19). 
Patients with diabetic neuropathy have few 
complaints, and their physical examination may 
reveal variable degrees of sensory loss (20). In our 
study, 28% of all subjects experienced numbness 
and 30% showed abnormal tendon reflex. Reduction 
in pain perception on neurological examinations, 
abnormal tendon reflex, and numbness were more 
significant in-group A, compared to group B. The 
frequency of abnormal pain sensation, paresthesia, 
and burning sensation was estimated at 18%, 6%, 
and 8%, respectively. Neurological examination 
was suggestive of impaired temperature sensation, 
reduced pain perception, reduced vibration 
perception, abnormal tendon reflex, and impaired 
touch perception in 12%, 0%, 10%, 30%, and 6% 
of subjects, respectively. 
The present findings revealed a positive correlation 
between clinical symptoms and abnormal NCV 
with sensitivity of 91.7% and specificity of 
84.2% (Table 3). Therefore, serial neurological 
examinations could be used for the diagnosis of 
diabetic neuropathy in clinics. Deep peroneal and 
sural nerves were the most commonly affected 
nerves in our patients (18); moreover, in two 
patients, the mentioned diagnosis associated with 
carpal tunnel syndrome was detected. 








Absent 24 (63.2) 3 (25)
Kappa=0.290
P-Value=0.021Present 14 (36.8) 9 (75)
Total 38 (100) 12 (100)
Abnormal symptoms
Absent 32 (84.2) 1 (8.3)
Kappa=0.664
Sig<0.001
Present 6 (15.8) 11(91.7)
Total 38 (100) 12 (100)
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Although hyperglycemia plays a crucial role in the 
progression of DPN, DPN can also occur without 
hyperglycemia (21, 22). The 24-yr prospective 
study of 32 newly diagnosed patients with type 
1 diabetes and comparing well controlled with 
poorly controlled patients, showed that near- 
normoglycemic control from the diagnosis over a 
24 yr was associated with a strong prevention of 
peripheral neuropathy development (23).
Our results revealed that poor diabetes control 
could be associated with DPN, and HbA1c level, 
used as an index for glycemic control over the 
past six months. A previous study has suggested 
an association between hyperlipidemia and DPN 
(24); however, in Jaiswal .M et.al study have not 
confirmed this correlation, similar to the present 
study(25). The prevalence of diabetic peripheral 
neuropathy was 7% in youth with type 1 diabetes 
and risk factors were older age, longer diabetes 
duration, increased blood pressure, obesity, 
increased LDL cholesterol and triglycerides (25). 
In fact, in the present study, diabetic neuropathy 
had no positive correlation with age, sex, BMI, 
duration of disease, or hyperlipidemia, whereas a 
significant correlation between HbA1c level and 
diabetic neuropathy was observed.
In conclusion, the best strategy to prevent diabetic 
neuropathy is rigid blood glucose control and 
periodic neurological examinations and the 
poor glycemic control is a determining factor in 
peripheral neuropathy in type 1 diabetic patients.
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